Cough Suppressant Drugs Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-01-21　·　153 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 1,524.6 Mn
2033 年預估規模: USD 1,966.1 Mn
年複合成長率 CAGR: 3.7%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Healthcare & Life Sciences出版日期 2026-01-21頁數 153報告編號 CMI2427

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Cough Suppressant Drugs Market, By Disease Type (Dry Cough and Wet Cough), By Drug Type (Dextromethorphan, Codeine, Noscapine, Butamirate, Benzonatate, Pholcodine, and Others), By Product Type (Over-the-counter (OTC) and Prescription Drug), By Age Group (Pediatric and Adult), By Dosage Form (Syrup, Tablet, and Others), By Distribution Channel (Hospital, Retail Pharmacy, Online Pharmacy, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

報告摘要

A cough is a most common symptom of various upper and lower respiratory tract infections. It affects a large proportion of the population leading them to seek medical attention. According to the data published by Journal of the Association of Physicians of India in 2016, cough was identified as the sixth most common reason for hospital outpatient department visits. Cough suppressants, also known as antitussives, are medications that help to suppress cough. Some of the examples of cough suppressants are Dextromethorphan, Codeine, Noscapine, Butamirate, Benzonatate, and Pholcodine. Dextromethorphan and Codeine are the most common and widely used cough suppressant in market. Market Dynamics Frequent launch of new cough suppressants in the market by key players is expected to drive the cough suppressant drugs market growth over the forecast period. For instance, in March 2018, Perrigo Company plc. received the FDA approval for the brand OTC equivalent of Mucinex DM Maximum Strength (Guaifenesin and Dextromethorphan Hydrobromide Extended-release Tablets, 1200 mg/60 mg). Mucinex DM Maximum Strength is indicated to control coughs and to break up mucus, making coughs more productive. Various key players in the market are conducting research and are evaluating safety and efficacy of various drugs for the treatment of cough. Such initiatives taken by companies is expected to lead to the development of new cough suppressant drugs. For instance, CSPC ZhongQi Pharmaceutical Technology Co., Ltd. is evaluating the efficacy and safety of benzonatate soft capsules for improving adult cough symptoms, wherein the study is currently (2018) under phase 3 clinical trial. Moreover, high prevalence of cough is expected to increase the demand for cough suppressant drugs, thereby driving the market growth. For instance, according to the study published by the National Center for Biotechnology Information in 2013, cough is a very common condition and around 12% of the people in Britain experience chronic cough, daily or weekly. Key features of the study • This report provides in-depth analysis of cough suppressant drugs market and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2026 – 2033), considering 2025 as the base year • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by leading players • It profiles leading players in the global cough suppressant drugs market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans • Key companies covered as a part of this study include Perrigo Company plc, Vernalis plc, Tris Pharma Inc., Pfizer Inc., Aytu BioScience, Inc., Acella Pharmaceuticals LLC, Mayne Pharma Inc., Taro Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Aurobindo Pharma Ltd, and GlaxoSmithKline plc. • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics • The global cough suppressant drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the cough suppressant drugs market Market Segmentation • Disease Type Insights (Revenue, USD Mn, 2026 - 2033) o Dry Cough o Wet Cough • Drug Type Insights (Revenue, USD Mn, 2026 - 2033) o Dextromethorphan o Codeine o Noscapine o Butamirate o Benzonatate o Pholcodine o Others • Product Type Insights (Revenue, USD Mn, 2026 - 2033) o Over-the-counter (OTC) o Prescription Drug • Age Group Insights (Revenue, USD Mn, 2026 - 2033) o Pediatric o Adult • Distribution Channel Insights (Revenue, USD Mn, 2026 - 2033) o Hospital o Retail Pharmacy o Online Pharmacy o Others • Regional Insights (Revenue, USD Mn, 2026 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Perrigo Company plc o Vernalis plc o Tris Pharma Inc. o Pfizer Inc. o Aytu BioScience, Inc. o Acella Pharmaceuticals LLC o Mayne Pharma Inc. o Taro Pharmaceutical Industries Ltd. o Amneal Pharmaceuticals LLC o Aurobindo Pharma Ltd o GlaxoSmithKline plc.

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snippet, By Disease Type  Market Snippet, By Drug Type  Market Snippet, By Product Type  Market Snippet, By Age Group  Market Snippet, By Distribution Channel  Market Snippet, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  PEST Analysis  PORTER’s Five Forces Analysis  Market Opportunities  Regulatory Scenario  Key Developments  Industry Trend 4. Global Cough Suppressant Drugs Market, By Disease Type, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Dry Cough  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Wet Cough  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends 5. Global Cough Suppressant Drugs Market, By Drug Type, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Dextromethorphan  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Codeine  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Noscapine  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Butamirate  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Benzonatate  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Pholcodine  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Others  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends 6. Global Cough Suppressant Drugs Market, By Product Type, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Over-the-counter (OTC)  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Prescription Drug  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends 7. Global Cough Suppressant Drugs Market, By Age Group, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Pediatric  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Adult  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends 8. Global Cough Suppressant Drugs Market, By Distribution Channel, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Hospital  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Retail Pharmacy  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Online Pharmacy  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Others  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends 9. Global Cough Suppressant Drugs Market, By Region, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, By Region, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, For Region, 2021 - 2033 o North America  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Disease Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Drug Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Product Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Age Group, 2026- 2033, (USD Mn)  Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)  Market Size and Forecast, By Country, 2026- 2033, (USD Mn) o U.S. o Canada o Latin America  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Disease Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Drug Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Product Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Age Group, 2026- 2033, (USD Mn)  Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)  Market Size and Forecast, By Country, 2026- 2033, (USD Mn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Disease Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Drug Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Product Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Age Group, 2026- 2033, (USD Mn)  Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)  Market Size and Forecast, By Country, 2026- 2033, (USD Mn) o U.K. o Germany o Italy o France o Spain o Russia o Rest of Europe o Asia Pacific  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Disease Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Drug Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Product Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Age Group, 2026- 2033, (USD Mn)  Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)  Market Size and Forecast, By Country, 2026- 2033, (USD Mn) o China o India o Japan o ASEAN o Australia o South Korea o Rest of Asia Pacific o Middle East  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Disease Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Drug Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Product Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Age Group, 2026- 2033, (USD Mn)  Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)  Market Size and Forecast, By Country, 2026- 2033, (USD Mn) o GCC Countries o Israel o Rest of Middle East o Africa  Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033  Market Size and Forecast, By Disease Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Drug Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Product Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Age Group, 2026- 2033, (USD Mn)  Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)  Market Size and Forecast, By Country, 2026- 2033, (USD Mn) o South Africa o North Africa o Central Africa 10. Competitive Landscape o Heat Map Analysis o Market Share Analysis (3x3 Matrix) o Company Profiles  Perrigo Company plc o Company Overview o Product Type Portfolio o Recent Developments/Updates  Vernalis plc o Company Overview o Product Type Portfolio o Recent Developments/Updates  Tris Pharma Inc. o Company Overview o Product Type Portfolio o Recent Developments/Updates  Pfizer Inc. o Company Overview o Product Type Portfolio o Recent Developments/Updates  Aytu BioScience, Inc. o Company Overview o Product Type Portfolio o Recent Developments/Updates  Acella Pharmaceuticals LLC o Company Overview o Product Type Portfolio o Recent Developments/Updates  Mayne Pharma Inc. o Company Overview o Product Type Portfolio o Recent Developments/Updates  Taro Pharmaceutical Industries Ltd. o Company Overview o Product Type Portfolio o Recent Developments/Updates  Amneal Pharmaceuticals LLC o Company Overview o Product Type Portfolio o Recent Developments/Updates  Aurobindo Pharma Ltd o Company Overview o Product Type Portfolio o Recent Developments/Updates  GlaxoSmithKline plc. o Company Overview o Product Type Portfolio o Recent Developments/Updates 11. Analyst Recommendation o Wheel of Fortune o Analyst View o Coherent Opportunity Map 12. Section o References o Research Methodology o About Us and Sales Contact

提及公司

Perrigo Company plcVernalis plcTris Pharma Inc.Pfizer Inc.Aytu BioScience, Inc.Acella Pharmaceuticals LLCMayne Pharma Inc.Taro Pharmaceutical Industries Ltd.Amneal Pharmaceuticals LLCAurobindo Pharma LtdGlaxoSmithKline plc.

同分類最新報告（醫療與生命科學）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們